Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33031031.
- Also identified by DOI 10.7554/eLife.62655 and PMC identifier 7544508.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Biochemical studies suggested that the antimicrobial peptide apidaecin (Api) inhibits protein synthesis by binding in the nascent peptide exit tunnel and trapping the release factor associated with a terminating ribosome. The mode of Api action in bacterial cells had remained unknown. Here genome-wide analysis reveals that in bacteria, Api arrests translating ribosomes at stop codons and causes pronounced queuing of the trailing ribosomes. By sequestering the available release factors, Api promotes pervasive stop codon bypass, leading to the expression of proteins with C-terminal extensions. Api-mediated translation arrest leads to the futile activation of the ribosome rescue systems. Understanding the unique mechanism of Api action in living cells may facilitate the development of new medicines and research tools for genome exploration.
Medical subject headings
- Antimicrobial Cationic Peptides
- Codon, Terminator
- Escherichia coli
- Genome, Bacterial
- Peptide Chain Termination, Translational
- Ribosomes